200 related articles for article (PubMed ID: 26383972)
1. Translational control of PML contributes to TNFα-induced apoptosis of MCF7 breast cancer cells and decreased angiogenesis in HUVECs.
Hsu KS; Guan BJ; Cheng X; Guan D; Lam M; Hatzoglou M; Kao HY
Cell Death Differ; 2016 Mar; 23(3):469-83. PubMed ID: 26383972
[TBL] [Abstract][Full Text] [Related]
2. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
3. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).
Cheng X; Liu Y; Chu H; Kao HY
J Biol Chem; 2012 Jul; 287(28):23356-67. PubMed ID: 22589541
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis revealing common and distinct functions of promyelocytic leukemia protein (PML) and tumor necrosis factor alpha (TNFα) signaling in endothelial cells.
Cheng X; Kao HY
BMC Genomics; 2012 Sep; 13():453. PubMed ID: 22947142
[TBL] [Abstract][Full Text] [Related]
5. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
6. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
7. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
Komura N; Asakawa M; Umezawa K; Segawa K
Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
[TBL] [Abstract][Full Text] [Related]
9. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
[TBL] [Abstract][Full Text] [Related]
12. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
Bernardi R; Guernah I; Jin D; Grisendi S; Alimonti A; Teruya-Feldstein J; Cordon-Cardo C; Simon MC; Rafii S; Pandolfi PP
Nature; 2006 Aug; 442(7104):779-85. PubMed ID: 16915281
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover.
Lim JH; Liu Y; Reineke E; Kao HY
J Biol Chem; 2011 Dec; 286(52):44403-11. PubMed ID: 22033920
[TBL] [Abstract][Full Text] [Related]
14. Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein.
Shimada N; Shinagawa T; Ishii S
Genes Cells; 2008 Mar; 13(3):245-54. PubMed ID: 18298799
[TBL] [Abstract][Full Text] [Related]
15. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
[TBL] [Abstract][Full Text] [Related]
16. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
17. The promyelocytic leukemia protein represses A20-mediated transcription.
Wu WS; Xu ZX; Chang KS
J Biol Chem; 2002 Aug; 277(35):31734-9. PubMed ID: 12080044
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway.
Wu WS; Xu ZX; Hittelman WN; Salomoni P; Pandolfi PP; Chang KS
J Biol Chem; 2003 Apr; 278(14):12294-304. PubMed ID: 12540841
[TBL] [Abstract][Full Text] [Related]
19. A cytoplasmic PML mutant inhibits p53 function.
Bellodi C; Kindle K; Bernassola F; Cossarizza A; Dinsdale D; Melino G; Heery D; Salomoni P
Cell Cycle; 2006 Nov; 5(22):2688-92. PubMed ID: 17172828
[TBL] [Abstract][Full Text] [Related]
20. PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.
Crowder C; Dahle Ø; Davis RE; Gabrielsen OS; Rudikoff S
Blood; 2005 Feb; 105(3):1280-7. PubMed ID: 15459016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
